Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
View/ Open
Published version
Embargoed until: 5555-01-01
Reason: Version not permitted.
Embargoed until: 5555-01-01
Reason: Version not permitted.
Volume
70
Pagination
865 - 875
DOI
10.1136/gutjnl-2021-324388
Journal
GUT
Issue
ISSN
0017-5749
Metadata
Show full item recordAuthors
Kennedy, NA; Goodhand, JR; Bewshea, C; Nice, R; Chee, D; Lin, S; Chanchlani, N; Butterworth, J; Cooney, R; Croft, NMCollections
- Centre for Immunobiology [1121]